Related Experiment Videos
[Relationship between drug resistance and oncogenes in lung cancer cell lines]
1Department of Medicine III, Osaka University Medical School.
Abstract:
The 5-year survival of lung cancer patients is about 30% in Japan. One of the reasons for the poor prognosis seems to be drug resistance. It has been reported that certain types of oncogenes, such as ras, myc and fos, may play an important role in drug resistance. The myc protein forms a sequence-specific DNA-binding complex with Max and may act as a transcription factor; thus, it may be possible that myc family oncogenes are involved in DNA synthesis and repair processes mediating drug resistance. We report here that L-myc oncogene may be involved in the transition from drug-sensitive to drug-resistant phenotype of a certain small cell lung cancer cell line.
Insights
Lung cancer patients in Japan have a poor 5-year survival rate, partly due to drug resistance. This study suggests the L-myc oncogene may drive the shift from drug-sensitive to drug-resistant small cell lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Lung cancer poses a significant health challenge, with a low 5-year survival rate in Japan.
- Drug resistance is a major factor contributing to poor prognosis in lung cancer patients.
- Oncogenes like ras, myc, and fos are implicated in the development of drug resistance.
Purpose:
- To investigate the role of the L-myc oncogene in the development of drug resistance in small cell lung cancer.
- To explore the potential involvement of myc family oncogenes in DNA synthesis and repair processes related to drug resistance.
Summary:
- This research focuses on a small cell lung cancer cell line, examining the transition from a drug-sensitive to a drug-resistant state.
- The study identifies the L-myc oncogene as a potential key player in mediating this phenotypic switch.
- The myc protein's function as a transcription factor suggests a mechanism involving DNA processes in drug resistance.
Impact:
- Findings may elucidate mechanisms of drug resistance in small cell lung cancer.
- Identifying the role of L-myc could lead to novel therapeutic strategies targeting drug resistance.
- This research contributes to understanding the genetic underpinnings of cancer treatment failure.